Patent intelligence · CA
CA 1341505
PREPARATION D'IMMUNOGLOBULINE POLYCLONALE CONTENANT DE L'IGM, AUX FINS D'ADMINISTRATION INTRAVEINEUSE, AINSI QUE SA METHODE DE FABRICATION
PREPARATION D'IMMUNOGLOBULINE POLYCLONALE CONTENANT DE L'IGM, AUX FINS D'ADMINISTRATION INTRAVEINEUSE, AINSI QUE SA METHODE DE FABRICATION
Patent details — CA 1341505
- Jurisdiction
- CA
- Status
- expired
- Grant date
- May 9, 2006
- Expiration
- May 4, 2026
- Applicant
- BIOTEST PHARMA GMBH [DE]
- CPC classes
- A61K 39/ 40 A I, A61K 39/ 395 A I, A61K/39395, A61K/3939591
Quick answer
CA 1341505 (PREPARATION D'IMMUNOGLOBULINE POLYCLONALE CONTENANT DE L'IGM, AUX FINS D'ADMINISTRATION INTRAVEINEUSE, AINSI QUE SA METHODE DE FABRICATION) is held by BIOTEST PHARMA GMBH [DE]. Status: expired. Granted May 9, 2006. Expires May 4, 2026 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BIOTEST PHARMA GMBH [DE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 39/ 40 A I, A61K 39/ 395 A I, A61K/39395, A61K/3939591, A61P 31/ 04 A I, A61P/3104
More from BIOTEST PHARMA GMBH [DE]
Related pharmaceutical patents in our USPTO index.
-
DK 0781560
Anvendelse af immunoglobulinpræparater til fremstilling af et medikament til oral indgivelse til behandling og forebyggelse
expired -
AT E191006
MENSCHLICHE MONOKLONALE ANTIKÖRPER GEGEN RHESUS D UND ZELLINIEN DIE DIESE PRODUZIEREN
expired -
DE 69229278
HUMANISIERTER B-B10, EIN ANTI-IL-2-REZEPTOR-ANTIKÖRPER
expired
Frequently asked questions
What is US patent 1341505?
CA 1341505 (PREPARATION D'IMMUNOGLOBULINE POLYCLONALE CONTENANT DE L'IGM, AUX FINS D'ADMINISTRATION INTRAVEINEUSE, AINSI QUE SA METHODE DE FABRICATION) is held by BIOTEST PHARMA GMBH [DE]. Status: expired. Granted May 9, 2006. Expires May 4, 2026 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns CA 1341505?
BIOTEST PHARMA GMBH [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 4 pharmaceutical patents for this assignee.
When does CA 1341505 expire?
Our index shows an expiration date of May 4, 2026 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.